Articles

Modulight Spotlights: LASER-SHARP RESEARCH – May 2026

Laser-sharp Research / immunology, immunotherapy, laser-sharp research, light activation, liposomes, ML6600, pancreatic cancer, Photoimmunotherapy / May 20, 2026

Modulight Spotlights: LASER-SHARP RESEARCH – May 2026 The research spotlight goes this month to Nimit Shah and the team from Dr. Girgis Obaid’s Lab Molecular Imaging and Optical Nanotherapeutics at University of Texas, Dallas. They developed and evaluated light-activated, verteporfin-containing liposomes for pancreatic cancer. This cancer is notoriously difficult to treat and more effective therapies are [...]

Modulight Spotlights: LASER-SHARP RESEARCH – May 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – April 2026

Laser-sharp Research / 689 nm, cancer, immunotherapy, IR700, laser therapy, laser-sharp research, ML7710, peptides, Photoimmunotherapy, targeted therapies, tumor / April 27, 2026

Modulight Spotlights: LASER-SHARP RESEARCH – April 2026 This month we are pleased to highlight new interesting article by Naoya Kondo and the team at Kansai Medical University in Japan. They developed a cancer cell-targeted photoimmunotherapy compound consisting of IR700 photoabsorber conjugated to bicyclic peptide. Use of small peptide could speed drug clearance from the body

Modulight Spotlights: LASER-SHARP RESEARCH – April 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – March 2026

Laser-sharp Research / chemo resistance, in vitro, in vivo, laser-sharp research, ML7710, ML8500, National Cancer Institute, ovarian cancer, peritoneal carcinoma, photoimmunoconjugates, Photoimmunotherapy, targeted therapies, University of Maryland / March 12, 2026

Modulight Spotlights: LASER-SHARP RESEARCH – March 2026 The development of chemoresistance presents a major challenge in treating peritoneal metastasis, which often occurs in advanced ovarian cancer. To tackle this, Kaitlyn Moore and teams at University of Maryland and National Cancer Institute evaluated photoimmunotherapy as a solution to inhibit a drug efflux pump on cancer cells

Modulight Spotlights: LASER-SHARP RESEARCH – March 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – February 2026

Laser-sharp Research / antibodies, Cancer therapy, laser therapy, laser-sharp research, ML7710, next generation therapies, peptides, Photoimmunotherapy, tumor / February 27, 2026

Modulight Spotlights: LASER-SHARP RESEARCH – February 2026 This month, we are highlighting promising work by Professor Hirofumi Hanaoka’s team at Kansai Medical University, Photo-ImmunoTherapy Research Institute. They developed a novel peptide-based photoimmunotherapy drug that targets PD-L1, which is expressed on many types of cancer cells. Preclinical experiments showed significant suppression of tumor growth and an

Modulight Spotlights: LASER-SHARP RESEARCH – February 2026 Read More »

Next-Generation Sequencing

Application Note / 488 nm, 535 nm, 594 nm, 640 nm, 660 nm, Dequencing optics, DNA, DNA sequencing, fluorescence detection, high-throughput sequencing, laser engine, ML6600, multi-wavelength lasers, NGS, nucleotides, SBS sequencing, sequencing, sequencing illumination / February 11, 2026

Learn how Modulight’s ML6600 laser engine enhances DNA and RNA sequencing accuracy with stable multi-wavelength illumination, precision optics, and fully integrated design for next-generation sequencing systems. Modulight’s in-house laser platform delivers all key excitation wavelengths, including 532 nm (green), 640—660 nm (red), 780—790 nm (IR), and 570—630 nm (yellow-orange).

Next-Generation Sequencing Read More »

Research tests light-activated treatment for brain cancer

Modulight in Media / February 2, 2026

The treatment pairs photodynamic therapy — a technique that uses light to activate cancer-killing compounds — with a novel nanoparticle drug developed by Joe Huang, an associate professor in the Fischell Department of Bioengineering at the University of Maryland. Researchers observed that the nanoformulation of verteporfin, known as NanoVP, significantly increases both potency and tumor penetration

Research tests light-activated treatment for brain cancer Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – January 2026

Laser-sharp Research / apoptosis, BPD, cancer, ferroptosis, in vitro, in vivo, laser-sharp research, light activation, ML6600, ovarian cancer, Photoimmunotherapy, photosensitizer / January 28, 2026

Modulight Spotlights: LASER-SHARP RESEARCH – January 2026 The highlight of the month goes to teams of researchers led by Prof. Imran Rizvi at University of North Carolina at Chapel Hill. Their latest publication shows that certain light-activated therapy with BPD photosensitizer and ML6600 laser can induce ferroptosis-like cell death, including formation of lipid peroxides, in

Modulight Spotlights: LASER-SHARP RESEARCH – January 2026 Read More »

Modulight Introduces High-Power Yellow and Orange Lasers to Bridge the “Yellow-Orange Gap”

Press Releases / 488 nm, 493 nm, 532 nm, 561 nm, 570 nm, 572 nm, 577 nm, 578 nm, 589 nm, 614 nm, 615 nm, 630 nm, astronomy, coagulation, dermatology, flow cytometry, genomics, light projection, medical, microscopy, ML6600, ophthalmology, orange, quantum computing, quantum sensing, usability, VECSEL, Yellow, yellow-orange-gap / January 20, 2026

Modulight announces yellow and orange laser wavelengths with several watts of output power, excellent beam quality, and unmatched flexibility. Traditionally difficult to achieve, Modulight’s VECSEL-based ML6600 series lasers now close the yellow-orange gap between 570 and 630 nm.

Modulight Introduces High-Power Yellow and Orange Lasers to Bridge the “Yellow-Orange Gap” Read More »

Modulight Launches ML6600-Based Mid-IR Laser for Medical, Aerospace, and Remote Sensing Applications

Press Releases / 2.7 um, 2.8 um, 2.9 um, aerospace, ceramics, CW, fiber laser, glasses, humidity monitoring, industrial, medical, Mid-IR, ML6600, ML6615, polymers, QCW, remote sensing, tissue cutting / January 19, 2026

A new addition to Modulight’s Fiber Laser Portfolio, ML6615, is a Mid-IR laser with 2.7–3 µm wavelength. The ML6615 laser is well-suited for soft tissue and dental treatments, and cutting, welding, and micro-machining polymers and certain glasses and ceramics. In aerospace and remote sensing, the system opens possibilities for specialized applications such as humidity and remote sensing tasks. ML6615 delivers up to 10 W of output power, supportiong both CW and QCW operating modes.

Modulight Launches ML6600-Based Mid-IR Laser for Medical, Aerospace, and Remote Sensing Applications Read More »